Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study
Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute cor...
Saved in:
Published in | Lipids in health and disease Vol. 19; no. 1; p. 5 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
11.01.2020
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS).
This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD).
Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015).
LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice. |
---|---|
AbstractList | Abstract
Background
Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS).
Methods
This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (
n
= 224,837) and newly defined high-risk patients (
n
= 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD).
Results
Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015).
Conclusions
LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice. BACKGROUNDReal-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS).METHODSThis was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD).RESULTSOverall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015).CONCLUSIONSLDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice. Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS). This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD). Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015). LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice. Abstract Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS). Methods This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD). Results Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015). Conclusions LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice. Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS). Methods This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD). Results Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015). Conclusions LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice. Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS). Methods This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD). Results Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015). Conclusions LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice. Keywords: Dyslipidaemia, Low density lipoprotein cholesterol, Stroke, Acute coronary syndrome, Cardiovascular disease, Diabetes mellitus, Statin Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to assess the status of dyslipidemia management, especially in high-risk patients with cardiovascular disease (CVD) including stroke and acute coronary syndrome (ACS). This was a retrospective cohort study of 514,866 subjects from the National Health Insurance Service-National Health Screening Cohort database in Korea. Participants were followed up from 2002 to 2015. Subjects with a high-risk of CVD prior to LDL-C measurement and subjects who were newly-diagnosed for high-risk of CVD following LDL-C measurement were defined as known high-risk patients (n = 224,837) and newly defined high-risk patients (n = 127,559), respectively. Data were analyzed by disease status: stroke, ACS, coronary heart disease (CHD), peripheral artery disease (PAD), diabetes mellitus (DM) and atherosclerotic artery disease (AAD). Overall, less than 50% of patients in each disease category achieved LDL-C goals (LDL-C < 70 mg/dL in patients with stroke, ACS, CHD and PAD; and LDL-C < 100 mg/dL in patients with DM and AAD). Statin use was observed in relatively low proportions of subjects (21.5% [known high-risk], 34.4% [newly defined high-risk]). LDL-C goal attainment from 2009 to 2015 steadily increased but the goal-achiever proportion of newly defined high-risk patients with ACS remained reasonably constant (38.7% in 2009; 38.1% in 2015). LDL-C goal attainment rates in high-risk patients with CVD and DM in Korea demonstrate unmet medical needs. Proactive management is necessary to bridge the gap between the recommendations of clinical guidelines and actual clinical practice. |
ArticleNumber | 5 |
Audience | Academic |
Author | Yang, Bo Ram Kim, Mi-Sook Choi, Sung Hee Yang, Ye Seul Hwang, Yunji |
Author_xml | – sequence: 1 givenname: Ye Seul surname: Yang fullname: Yang, Ye Seul organization: Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea – sequence: 2 givenname: Bo Ram surname: Yang fullname: Yang, Bo Ram organization: Medical Research Collaborating Center, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea – sequence: 3 givenname: Mi-Sook surname: Kim fullname: Kim, Mi-Sook organization: Department of Preventive Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Republic of Korea – sequence: 4 givenname: Yunji surname: Hwang fullname: Hwang, Yunji organization: Amgen Korea, 19 Eulji-ro 5-gil, Jung-gu, Seoul, Republic of Korea – sequence: 5 givenname: Sung Hee orcidid: 0000-0003-0740-8116 surname: Choi fullname: Choi, Sung Hee email: shchoimd@gmail.com, shchoimd@gmail.com organization: Department of Internal Medicine, Division of Endocrinology & Metabolism, Seoul National University Bundang Hospital, 82, Gumi-ro 173Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea. shchoimd@gmail.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31926562$$D View this record in MEDLINE/PubMed |
BookMark | eNptks1u1DAUhSNURNuBB2CDLLHpJsWOf5KwQKoqfipGYgMSO-vGvpnxkIkH25lqHom3xNMppYNQFknsc74rH5_z4mT0IxbFS0YvGWvUm8iqVoiSsrZkTDalfFKcMVGrUjL2_eTR92lxHuOK0orWSj0rTjlrKyVVdVb8mvvb0uIYXdqRwW38JviEbiRm6QeMCYMfyMLDQCAlcOMax0QCJIwki5ZusSyDiz_IBpLLW5HcurQkBoJ1fgvRTAMEYl1EiNkCo80_0OHev8ZhcGm6A332AeEtARIwBR83aJLbIjF-6UMiMU1297x42sMQ8cX9e1Z8-_D-6_Wncv7l48311bw0UtFUGqwYglTc2LZr-srUnbFS9EJBW3fYKMlZB73gKKiBWlnkTdv2AvumV401fFbcHLjWw0pvgltD2GkPTt8t-LDQEJIzA-oWbQON7SWXGchqkBlRdW1lBac8T5oV7w6szdSt0ZqcUIDhCHq8M7qlXvitVq0UUrYZcHEPCP7nlO9Dr100OTgY0U9RV5zXtK4oo1n6-h_pyk9hzFFllWBcCtayv6oF5AO4sfd5rtlD9ZViTc1qQfdjL_-jyo_FtTO5hL3L60cGdjCYfHsxYP9wRkb1vqv60FWdu6r3XdX7cF49DufB8aec_DdU_usD |
CitedBy_id | crossref_primary_10_12997_jla_2023_12_2_175 crossref_primary_10_1097_MCA_0000000000001138 crossref_primary_10_1016_j_ijcard_2021_12_020 crossref_primary_10_1016_j_cpcardiol_2021_101068 crossref_primary_10_4093_dmj_2022_0448 crossref_primary_10_4235_agmr_21_0099 crossref_primary_10_1016_j_dsx_2023_102784 crossref_primary_10_1016_j_ajpc_2020_100040 crossref_primary_10_1186_s12944_021_01455_3 crossref_primary_10_1016_j_ijcard_2020_06_059 crossref_primary_10_4093_dmj_2021_0088 crossref_primary_10_1089_met_2023_0310 crossref_primary_10_4103_hm_hm_3_20 crossref_primary_10_1016_j_jacl_2023_04_002 crossref_primary_10_1186_s12933_022_01495_8 crossref_primary_10_1186_s12933_021_01338_y crossref_primary_10_1371_journal_pone_0296298 crossref_primary_10_12997_jla_2023_12_1_12 crossref_primary_10_12997_jla_2023_12_3_277 crossref_primary_10_1016_j_amjcard_2023_11_067 |
Cites_doi | 10.1016/j.clpt.2005.06.013 10.1016/j.atherosclerosis.2016.07.001 10.4093/dmj.2011.35.6.628 10.1161/01.cir.0000437738.63853.7a 10.1016/j.amjcard.2006.08.051 10.1111/j.1368-5031.2005.00646.x 10.1093/eurheartj/ehw272 10.1177/000331970505600611 10.1016/j.clinthera.2017.03.001 10.4158/EP171764.APPGL 10.1371/journal.pone.0191817 10.1016/j.ijcard.2018.04.068 10.1186/s12944-018-0945-8 10.1016/S0140-6736(10)61350-5 10.1371/journal.pone.0146272 10.1056/NEJM199811053391902 10.24304/kjcp.2017.27.4.276 10.1136/bmjopen-2017-016640 10.4093/dmj.2013.37.6.433 10.5551/jat.15792 10.1016/j.cjca.2016.07.510 10.3803/EnM.2017.32.1.30 10.1056/NEJM199610033351401 10.1016/j.ijcard.2018.01.099 10.4093/dmj.2017.41.1.20 10.1016/j.atherosclerosis.2017.11.020 10.7326/AITC201712050 10.1161/CIRCRESAHA.117.308903 10.1016/j.jacc.2016.03.519 10.1016/j.cjca.2016.10.019 10.1016/j.jacc.2018.11.002 10.3349/ymj.2017.58.2.326 10.1001/jama.285.19.2486 10.5551/jat.RV16004 10.1016/S0140-6736(16)31012-1 10.1056/NEJMoa050461 10.4070/kcj.2016.46.3.275 10.1080/03007995.2017.1292898 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2020 |
Copyright_xml | – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2020 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P P64 PIMPY PQEST PQQKQ PQUKI RC3 7X8 5PM DOA |
DOI | 10.1186/s12944-019-1158-5 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database Biotechnology and BioEngineering Abstracts Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Statistics |
EISSN | 1476-511X |
EndPage | 5 |
ExternalDocumentID | oai_doaj_org_article_9ed8a8df535f4317a5f682b92d430365 A618717409 10_1186_s12944_019_1158_5 31926562 |
Genre | Journal Article |
GeographicLocations | Republic of Korea South Korea |
GeographicLocations_xml | – name: Republic of Korea – name: South Korea |
GrantInformation_xml | – fundername: ; |
GroupedDBID | --- -A0 0R~ 29L 2WC 3V. 53G 5GY 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AAFWJ AAJSJ ABDBF ABUWG ACGFO ACGFS ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AENEX AFGXO AFKRA AFNRJ AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK E3Z EAD EAP EAS EBD EBS ECM EIF EMB EMK EMOBN ESTFP ESX F5P FRP FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IGS IHR INH INR ITC KQ8 LK8 M1P M48 M7P M~E NPM O5R O5S OK1 P2P P6G PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAHBH AAYXX ALIPV CITATION EBLON PGMZT ABVAZ 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ K9. P64 PQEST PQUKI RC3 7X8 5PM |
ID | FETCH-LOGICAL-c560t-ce21ea563cd9b8f2c7bcd54f46a97be86531baf43e40ca76de3899f4ef8f68dc3 |
IEDL.DBID | RPM |
ISSN | 1476-511X |
IngestDate | Thu Jul 04 21:11:28 EDT 2024 Tue Sep 17 21:25:48 EDT 2024 Sat Aug 17 05:43:56 EDT 2024 Fri Sep 13 01:26:37 EDT 2024 Fri Feb 23 00:12:48 EST 2024 Fri Feb 02 04:14:01 EST 2024 Thu Sep 12 16:21:13 EDT 2024 Thu May 23 23:26:12 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Stroke Diabetes mellitus Low density lipoprotein cholesterol Cardiovascular disease Dyslipidaemia Statin Acute coronary syndrome |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c560t-ce21ea563cd9b8f2c7bcd54f46a97be86531baf43e40ca76de3899f4ef8f68dc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-0740-8116 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954559/ |
PMID | 31926562 |
PQID | 2341354191 |
PQPubID | 42587 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_9ed8a8df535f4317a5f682b92d430365 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6954559 proquest_miscellaneous_2337072010 proquest_journals_2341354191 gale_infotracmisc_A618717409 gale_infotracacademiconefile_A618717409 crossref_primary_10_1186_s12944_019_1158_5 pubmed_primary_31926562 |
PublicationCentury | 2000 |
PublicationDate | 2020-01-11 |
PublicationDateYYYYMMDD | 2020-01-11 |
PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-11 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Lipids in health and disease |
PublicationTitleAlternate | Lipids Health Dis |
PublicationYear | 2020 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | JK Liao (1158_CR31) 2007; 99 Haidong Wang (1158_CR6) 2016; 388 L Kopin (1158_CR5) 2017; 167 SC Seong (1158_CR25) 2017; 46 E Lee (1158_CR30) 2005; 78 P Joseph (1158_CR7) 2017; 121 T Teramoto (1158_CR44) 2016; 251 1158_CR13 SK Kim (1158_CR32) 2017; 41 Long-Term Intervention with Pravastatin in Ischaemic Disease Study Group (1158_CR19) 1998; 339 JS Jeong (1158_CR11) 2017; 32 SC Seong (1158_CR24) 2017; 7 RS Punekar (1158_CR27) 2017; 33 R Naito (1158_CR29) 2017; 24 JG Kuiper (1158_CR38) 2017; 39 YH Lee (1158_CR10) 2014; 3 FD Hobbs (1158_CR37) 2005; 59 BP Yan (1158_CR39) 2018; 265 H Wouters (1158_CR33) 2016; 11 PS Jellinger (1158_CR4) 2017; 23 Y Choi (1158_CR16) 2017; 27 AL Catapano (1158_CR15) 2016; 37 JY Hwang (1158_CR35) 2011; 35 C Baigent (1158_CR21) 2010; 376 1158_CR26 1158_CR23 J Lee (1158_CR12) 2017; 58 Q Hou (1158_CR42) 2019; 18 DM Lloyd-Jones (1158_CR28) 2016; 68 1158_CR8 C Breuker (1158_CR41) 2018; 268 T Teramoto (1158_CR43) 2013; 20 W März (1158_CR40) 2018; 268 EJ Diamantopoulos (1158_CR36) 2005; 56 V Fung (1158_CR34) 2018; 13 1158_CR3 FM Sacks (1158_CR18) 1996; 335 E Roh (1158_CR9) 2013; 37 DD Waters (1158_CR17) 2017; 33 1158_CR2 TJ Anderson (1158_CR14) 2016; 32 1158_CR1 JC LaRosa (1158_CR20) 2005; 352 Scott M. Grundy (1158_CR22) 2019; 73 |
References_xml | – volume: 78 start-page: 330 issue: 4 year: 2005 ident: 1158_CR30 publication-title: Clin Pharmacol Ther doi: 10.1016/j.clpt.2005.06.013 contributor: fullname: E Lee – volume: 251 start-page: 248 year: 2016 ident: 1158_CR44 publication-title: Atheroscler doi: 10.1016/j.atherosclerosis.2016.07.001 contributor: fullname: T Teramoto – volume: 35 start-page: 628 issue: 6 year: 2011 ident: 1158_CR35 publication-title: Diab Metab J doi: 10.4093/dmj.2011.35.6.628 contributor: fullname: JY Hwang – ident: 1158_CR3 doi: 10.1161/01.cir.0000437738.63853.7a – volume: 99 start-page: 410 issue: 3 year: 2007 ident: 1158_CR31 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2006.08.051 contributor: fullname: JK Liao – ident: 1158_CR23 – volume: 59 start-page: 1171 issue: 10 year: 2005 ident: 1158_CR37 publication-title: Int J Clin Pract doi: 10.1111/j.1368-5031.2005.00646.x contributor: fullname: FD Hobbs – volume: 37 start-page: 2999 issue: 39 year: 2016 ident: 1158_CR15 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw272 contributor: fullname: AL Catapano – volume: 56 start-page: 731 issue: 6 year: 2005 ident: 1158_CR36 publication-title: Angiol doi: 10.1177/000331970505600611 contributor: fullname: EJ Diamantopoulos – volume: 39 start-page: 819 issue: 4 year: 2017 ident: 1158_CR38 publication-title: Clin Ther doi: 10.1016/j.clinthera.2017.03.001 contributor: fullname: JG Kuiper – ident: 1158_CR8 – volume: 23 start-page: 1 issue: Suppl 2 year: 2017 ident: 1158_CR4 publication-title: Endocr Pract doi: 10.4158/EP171764.APPGL contributor: fullname: PS Jellinger – volume: 13 start-page: e0191817 issue: 2 year: 2018 ident: 1158_CR34 publication-title: PLoS One doi: 10.1371/journal.pone.0191817 contributor: fullname: V Fung – volume: 268 start-page: 195 year: 2018 ident: 1158_CR41 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2018.04.068 contributor: fullname: C Breuker – volume: 18 start-page: 13 issue: 1 year: 2019 ident: 1158_CR42 publication-title: Lipids Health Dis doi: 10.1186/s12944-018-0945-8 contributor: fullname: Q Hou – volume: 376 start-page: 1670 year: 2010 ident: 1158_CR21 publication-title: Lancet doi: 10.1016/S0140-6736(10)61350-5 contributor: fullname: C Baigent – volume: 11 start-page: e0146272 issue: 1 year: 2016 ident: 1158_CR33 publication-title: PLoS One doi: 10.1371/journal.pone.0146272 contributor: fullname: H Wouters – volume: 339 start-page: 1349 issue: 19 year: 1998 ident: 1158_CR19 publication-title: N Engl J Med doi: 10.1056/NEJM199811053391902 contributor: fullname: Long-Term Intervention with Pravastatin in Ischaemic Disease Study Group – volume: 27 start-page: 276 issue: 4 year: 2017 ident: 1158_CR16 publication-title: Korean J Clin Pharm doi: 10.24304/kjcp.2017.27.4.276 contributor: fullname: Y Choi – volume: 7 issue: 9 year: 2017 ident: 1158_CR24 publication-title: BMJ Open doi: 10.1136/bmjopen-2017-016640 contributor: fullname: SC Seong – volume: 37 start-page: 433 issue: 6 year: 2013 ident: 1158_CR9 publication-title: Diabetes Metab J doi: 10.4093/dmj.2013.37.6.433 contributor: fullname: E Roh – volume: 20 start-page: 517 issue: 6 year: 2013 ident: 1158_CR43 publication-title: J Atheroscler Thromb doi: 10.5551/jat.15792 contributor: fullname: T Teramoto – volume: 32 start-page: 1263 issue: 11 year: 2016 ident: 1158_CR14 publication-title: Can J Cardiol. doi: 10.1016/j.cjca.2016.07.510 contributor: fullname: TJ Anderson – volume: 32 start-page: 30 issue: 1 year: 2017 ident: 1158_CR11 publication-title: Endocrinol Metab (Seoul) doi: 10.3803/EnM.2017.32.1.30 contributor: fullname: JS Jeong – volume: 335 start-page: 1001 issue: 14 year: 1996 ident: 1158_CR18 publication-title: N Engl J Med doi: 10.1056/NEJM199610033351401 contributor: fullname: FM Sacks – volume: 265 start-page: 1 year: 2018 ident: 1158_CR39 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2018.01.099 contributor: fullname: BP Yan – volume: 41 start-page: 20 issue: 1 year: 2017 ident: 1158_CR32 publication-title: Diab Metab J doi: 10.4093/dmj.2017.41.1.20 contributor: fullname: SK Kim – volume: 268 start-page: 99 year: 2018 ident: 1158_CR40 publication-title: Atheroscler doi: 10.1016/j.atherosclerosis.2017.11.020 contributor: fullname: W März – ident: 1158_CR1 – volume: 167 start-page: ITC81 year: 2017 ident: 1158_CR5 publication-title: Ann Intern Med doi: 10.7326/AITC201712050 contributor: fullname: L Kopin – volume: 121 start-page: 677 issue: 6 year: 2017 ident: 1158_CR7 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.117.308903 contributor: fullname: P Joseph – volume: 68 start-page: 92 issue: 1 year: 2016 ident: 1158_CR28 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.03.519 contributor: fullname: DM Lloyd-Jones – volume: 33 start-page: 343 issue: 3 year: 2017 ident: 1158_CR17 publication-title: Can J Cardiol doi: 10.1016/j.cjca.2016.10.019 contributor: fullname: DD Waters – ident: 1158_CR26 – volume: 46 start-page: 799 issue: 3 year: 2017 ident: 1158_CR25 publication-title: Int J Epidemiol contributor: fullname: SC Seong – volume: 73 start-page: 3168 issue: 24 year: 2019 ident: 1158_CR22 publication-title: Journal of the American College of Cardiology doi: 10.1016/j.jacc.2018.11.002 contributor: fullname: Scott M. Grundy – volume: 3 issue: 1 year: 2014 ident: 1158_CR10 publication-title: J Am Heart Assoc contributor: fullname: YH Lee – volume: 58 start-page: 326 issue: 2 year: 2017 ident: 1158_CR12 publication-title: Yonsei Med J doi: 10.3349/ymj.2017.58.2.326 contributor: fullname: J Lee – ident: 1158_CR2 doi: 10.1001/jama.285.19.2486 – volume: 24 start-page: 19 issue: 1 year: 2017 ident: 1158_CR29 publication-title: J Atheroscler Thromb doi: 10.5551/jat.RV16004 contributor: fullname: R Naito – volume: 388 start-page: 1459 issue: 10053 year: 2016 ident: 1158_CR6 publication-title: The Lancet doi: 10.1016/S0140-6736(16)31012-1 contributor: fullname: Haidong Wang – volume: 352 start-page: 1425 year: 2005 ident: 1158_CR20 publication-title: N Engl J Med doi: 10.1056/NEJMoa050461 contributor: fullname: JC LaRosa – ident: 1158_CR13 doi: 10.4070/kcj.2016.46.3.275 – volume: 33 start-page: 869 issue: 5 year: 2017 ident: 1158_CR27 publication-title: Curr Med Res Opin doi: 10.1080/03007995.2017.1292898 contributor: fullname: RS Punekar |
SSID | ssj0020766 |
Score | 2.372327 |
Snippet | Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study was to... Abstract Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of... Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this... BACKGROUNDReal-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of this study... Abstract Background Real-world evidence of low-density lipoprotein cholesterol (LDL-C) goal attainment rates for Asian patients is deficient. The objective of... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 5 |
SubjectTerms | Acute coronary syndrome Acute Coronary Syndrome - blood Acute Coronary Syndrome - pathology Acute coronary syndromes Aged Antilipemic agents Arteriosclerosis Atherosclerosis Atherosclerosis - blood Atherosclerosis - pathology Cardiac patients Cardiology Cardiovascular agents Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - blood Cardiovascular Diseases - pathology Care and treatment Carotid arteries Cholesterol Cholesterol tests Cholesterol, LDL - blood Codes Cohort analysis Coronary artery disease Coronary Disease - blood Coronary Disease - pathology Coronary heart disease Diabetes Diabetes mellitus Diabetes Mellitus - blood Diabetes Mellitus - pathology Diseases Dyslipidaemia Dyslipidemia Dyslipidemias Female Health Health aspects Health screening Heart diseases Humans LDL cholesterol Lipoproteins Low density lipoprotein Low density lipoprotein cholesterol Low density lipoproteins Male Medical screening Metabolic disorders Middle Aged National health insurance Patients Peripheral Arterial Disease - blood Peripheral Arterial Disease - pathology Republic of Korea - epidemiology Retrospective Studies Risk Factors Risk groups Society Statins Statistics Stroke Stroke - blood Stroke - pathology Stroke patients Vascular diseases |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9VAFB6kC3Ej2vqIVhlBFITQm2Se7q5iKWpdWehumKdeaJNyby7Sn-S_9JxJcrnBhRu3mZOQ5LxnvvmGkNdI6MJFbMrkcUuOrFhpZWRl0slrlpRdRGwUz7-Jswv2-ZJf7h31hZiwgR54-HEnOgZlVUi84QmTneVJqNrpOjCMvgN7acWnZmpstaA7F-MaZqXEyQayGkO0hS5BVpV8loUyWf_fIXkvJ83xknsJ6PQBuT9WjnQ5vPFDcie2h-Ro2ULXfH1L39CM5cyT5Ifk7vm4ZH5Efn_tfpUBYer9Lb1a3XSZmWHVUox7mSahu6I_Oniy7SdwAEX-iA0FIWQzLhF-TkcC1g3FmVvqZzBWOi7zbKhtA52mc-k1kn322_ygLx1Up--ppevYr7tpfyfF83nXPc0kt4_Ixemn7x_PyvF8htJDndSXPtZVtFw0PminUu2l84GzxITV0kUlwL-dBa1FtvBWihCRzC-xmBToMPjmMTlouzY-JTT5ELiUTjauYTxIx2xlmYUOOjgdAivIu0lf5mag4TC5fVHCDMo1oFyDyjW8IB9QoztBZNDOF8CuzGhX5l92VZC3aA8G_RyU7u24XQHeFxmzzFJU0GtKaI8LcjyTBP_08-HJoswYHzamxuKBM2iWC_JqN4x3Iuatjd0WZRq5kIhWKMiTwQB3nwSBswYfqwsiZ6Y5--b5SLv6mdnDhYaimetn_-MnPSf3apx_WFTgV8fkoF9v4wso0nr3MvvjHxu4PmY priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxQxFA61BfFFtPUyWiWCKAhhd2ZymfFFttKyqC0iFvoWMrnUhXZmnZ1F-pP8l54zm1k7CL5usiHDueRcvnwh5DUSugjpcxYsXslRKWdGec5CGWzJQ2GmHhPF0zM5P-efLsTFDpkPd2EQVjn4xN5Ru8ZijXySobsVHNKLiamwCmC7yYflT4bvR2GfNT6mcYfsZSnHhu3e0fHZ12_b5AvydRm7mmkhJys45zjiL0oGMVHBxOhc6un7_3XSt06pMYLy1pF08oDcj7EknW2E_5Ds-HqfHMxqyKOvb-gb2qM7-7L5Prl7GpvoB-T3l-YXcwhc727o1WLZ9FwNi5qiJ-yJE5oretnAyqYb4AIUGSVWFCYhvzFDQDqNlKwrirVcakfAVhobPytqakeHAi-9RvrPbt0v9LmBePU9NbT1XdsMNz4pvtjbdrSnvX1Ezk-Ov3-cs_hiA7MQOXXM-iz1RsjcurIqQmZVZZ3ggUtTqsoXEiy-MoHnnk-tUdJ5pPcL3IciyMLZ_DHZrZvaPyU0WOeEUpXKq5wLpypuUsMN5NSuKp3jCXk3yEsvN8Qcuk9oCqk3wtUgXI3C1SIhRyjR7UTk1O5_aNpLHU1Ul94VpnBB5CJgWGUE7CmrysxxPOdhkbeoDxotH_XPxAsMsF_k0NIzmUL2qSBhTsjhaCZYrB0PDxqlo8dY6b_6nZBX22H8J6Lgat-scU6upgrxCwl5slHA7SeBK83A6rKEqJFqjr55PFIvfvR84rKEMFqUz_6_refkXoa1hmkKFnNIdrt27V9AQNZVL6Ot_QHprDt8 priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bi9QwFA7rCrIvorNeqqtEEAWhOtPm0goio7gs6vjkwLyFNJd1YLZd2w46P8l_6TlpO2xxH3ydpJmm55zkO8mXL4Q8R0EXLlwae4NHcuSMxVo6Fvvcm5z5TE8dJoqLb-JsyT6v-OqADNdb9R-wuTa1w_uklvXm9e-fu_cQ8O9CwGfiTQNzFkMuRR4DvslifoPcTFjK0OEXbL-pkEDK3h02kiIGnLHqNzmvbWI0TQU1_3_H7CuT1phQeWWGOr1DbvfQks47X7hLDlw5IcfzEtLqix19QQPZM6yiT8itRb-nPiFHiDc7ueZj8udr9Su2SGpvd3SzvqyCjsO6pPihgqhCtaHnFfyNbgcqAUW1iYZCJdQ-jpGsTnu51obiOi81I9Ir7TeFGqpLS4fFX3qB0qDtNjT0pQIs-5ZqWru2robToBRv861bGiRx75Hl6afvH8_i_jaH2ACqamPjkpnTXKTG5kXmEyMLYznzTOhcFi4TMBoU2rPUsanRUliH0n-eOZ95kVmT3ieHZVW6h4R6Yy2XspBpkTJuZcH0TDMN-bYtcmtZRF4NxlOXnWiHCslOJlRnaQWWVmhpxSPyAc27r4h62-GHqj5Xffiq3NlMZ9bzlHuEXJrDOyVFnliGGAAaeYnOodBPwQOM7g83wPuivpaaixlkphKS6YicjGpCNJtx8eBeaggGlSDU4AxS64g82xfjk8iQK121xTqpnErkNkTkQeeN-y7BMJtARCYRkSM_HfV5XFKufwStcZEDxOb5o__u32NylOCSxHQGkXRCDtt6654AbmuLpyEa_wKgvUPe priority: 102 providerName: Scholars Portal |
Title | Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31926562 https://www.proquest.com/docview/2341354191/abstract/ https://search.proquest.com/docview/2337072010 https://pubmed.ncbi.nlm.nih.gov/PMC6954559 https://doaj.org/article/9ed8a8df535f4317a5f682b92d430365 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZtB2MvY2t38doFDcYGAzexrYu9t7S0lG0pZayQNyHr0gUSOyQOpT9p_3LnKHao2dte_GDJQuaco3PRp0-EfERCFy5cFnuDR3JkwmItHYt94U3BfK5HDhPFybW4umXfpny6R3h3FiaA9k05O63mi9Nq9jtgK5cLM-xwYsObybkowO_zYrhP9mWWdSl6m2VBYi7a7cskF8M1ODSGQIsihuAnj_GqGlC7FGaY9nxRoOz_d2F-5Jn6qMlHbujyBXnexo90vJ3nS7LnqkNyNK4gd1480E80IDpDqfyQPJ20G-dH5M-P-j62CFZvHuh8tqwDP8Osorj6BbKEek7vahhZNx1EgCKLxJpCJ-Q0jhGETlsa1jXF-i01PTArbTd71lRXlnZFXbpAys9mEwb6XkOM-pVqunLNqu5OeVK8pXfV0EB1-4rcXl78Or-K21saYgPRUhMblyZOc5EZW5S5T40sjeXMM6ELWbpcgJWX2rPMsZHRUliHlH6eOZ97kVuTvSYHVV25t4R6Yy2XspRZmTFuZcl0opmGPNqWhbUsIl86eanlloxDhSQmF2orZwVyVihnxSNyhhLddUQe7fCiXt2pVptU4Wyuc-t5xj2GUprDnNKySC1D3w6DfEZ9UGjtIHSj20MLMF_kzVJjkUDGKSFJjshJrydYqek3dxql2lVirVIMITiDlDkiH3bN-CUi3ypXb7BPJkcSMQsRebNVwN0vdXocEdlTzd4_91vApAKHeGtC7_77y2PyLMXSwygBuzohB81q495DfNaUA7DKqRyQJ2cX1zc_B6HKAc8JywfBUv8CqW5Dzw |
link.rule.ids | 230,315,733,786,790,870,891,2115,12083,21416,24346,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgSMALgg1GYICREEhI0ZrEl4QXVBBTYe2eNmlvluPLqLQlpU2F9pP4l5zjOt0iJF5r13J07sefPxPyDglduHBF6g1eyZEZS7V0LPWVNxXzpR45LBRnJ2Jyxn6c8_PYcFtFWGXvE4Ojtq3BHvlhju6WMygvPi9-pfhqFJ6uxic07pJ7rCgYQvrk-U3BBTW6iCeZWSkOVxDbGGIuqhTyoDLlg1gUKPv_dcy3ItMQNXkrDB09Jo9i_kjHG4E_IXdcs0v2xg3UzlfX9D0NiM7QKt8l92fx4HyP_Jm2v1OLYPXuml7OF23gZ5g3FL1fIEtoL-lFCyvrrocIUGSRWFGYhJzGKYLQaaRhXVHs31IzALPSeNizorqxtG_q0iuk_OzWYaHjFnLUT1TTpeuWbX_Lk-IrvcuOBqrbp-Ts6Nvp10kaX2lIDWRLXWpcnjnNRWFsVZc-N7I2ljPPhK5k7UoBVl5rzwrHRkZLYR1S-nnmfOlFaU3xjOw0beOeE-qNtVzKWhY1CNPKmulMMw11tK0ra1lCPvbyUosNGYcKRUwp1Ea4CoSrULiKJ-QLSnQ7EXm0ww_t8kJFs1SVs6UurecF95hKaQ57yusqtwxjOyzyAfVBobWD0I2OlxZgv8ibpcYig4pTQpGckIPBTLBSMxzuNUpFL7FSNzqdkLfbYfwnIt8a165xTiFHEjELCdnfKOD2k8B95mBpeULkQDUH3zwcaeY_A4e4qCB15tWL_2_rDXkwOZ1N1fT7yfFL8jDHXsMoA-s5IDvdcu1eQULW1a-D1f0FG8Y5SQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSBMvXDYuhQFGQiAhpW0Sx054K4NqsIv2wKSJF8vXUdEmVZsKjX_Ev-QcN6kaeNtrfWLZ6udzsT9_JuQNCrpk3KWRN3glR8QsUsKxyBfeFMznauiwUDw940cX7Otldrn11Fcg7Rs96ZfTWb-c_AjcyvnMDFqe2OD89JAXEPezYjC3fnCb3IE1mxRtod7UWlCe8-YQM875YAlhjSHdooggBcojfLAGwJfAOJNORArC_f-756341OVObgWj8X3yvZ3GmoPys7-qdd_8_kfh8UbzfEDuNSkqHa1NHpJbrtwj-6MSyvPZNX1LA2k07Mbvkd3T5mx-n_w5qX5FFvnw9TWdTuZVkICYlBQdbNBjqKb0qoKeVd2yECgKVSwpGKFscoQ8d9oovS4pbhFT0-HL0uY8aUlVaWm7b0xnqCpar0JHxxWkwR-oogtXL6r2IinFh4AXNQ1quo_Ixfjzt8OjqHkIIjKQkNWRcUnsVMZTYwud-8QIbWzGPOOqENrlHByJVp6ljg2NEtw6VA30zPnc89ya9DHZKavSPSXUG2szIbRIdcoyKzRTsWIKSnWrC2tZj7xvwSDna70PGeqknMs1iCSASCKIZNYjHxEuG0OU6g4_VIsr2fyRsnA2V7n1WZp5zNZUBmNKdJFYhukDdPIOwSbRoQCijGruRcB4UZpLjngMRa2AOrxHDjqW4AhMt7mFq2wc0VImmKVkDKryHnm9acYvkVxXumqFNqkYCqRF9MiTNbo3U2oXSY-IDu47c-62AJqDTHmD3mc3_vIV2T3_NJYnX86On5O7CW50DGNYvwdkp16s3AvIBmv9Mqz7v1-SZAI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Low-density+lipoprotein+cholesterol+goal+attainment+rates+in+high-risk+patients+with+cardiovascular+diseases+and+diabetes+mellitus+in+Korea%3A+a+retrospective+cohort+study&rft.jtitle=Lipids+in+health+and+disease&rft.au=Yang%2C+Ye+Seul&rft.au=Yang%2C+Bo+Ram&rft.au=Kim%2C+Mi-Sook&rft.au=Hwang%2C+Yunji&rft.date=2020-01-11&rft.pub=BioMed+Central+Ltd&rft.issn=1476-511X&rft.eissn=1476-511X&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12944-019-1158-5&rft.externalDocID=A618717409 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon |